Tim Kutzkey Ngm Biopharmaceuticals Inc

As of June 13, 2022


What is Tim Kutzkey's Net Worth?

The current estimated net worth of Ngm Biopharmaceuticals Inc's Tim Kutzkey is estimated to be about $558.25M . Tim Kutzkey owns about 134,442 units of Ngm Biopharmaceuticals Inc common stock. In the last 3 years at Ngm Biopharmaceuticals Inc, Tim Kutzkey has sold an estimated value of $0 worth.

What is Tim Kutzkey's Past Insider Trading?

Tim Kutzkey's largest purchase order was 14,983,134 units , worth over $30.24M on April 10, 2019. In total, Tim Kutzkey has made about 51 transactions over 3 years of their time at Ngm Biopharmaceuticals Inc. Tim Kutzkey usually trades in May, with the busiest year in 2019. The most recent transaction was a purchase order of 984,161 units , worth over $13.29M on June 13, 2022.

GROUP COLUMN, Peter Svennilson, Tim Kutzkey, Ponoi Capital II LP, Ponoi II Management LLC, PONOI CAPITAL LP, Ponoi Management LLC, COLUMN GROUP II LP, Column Group Management LP, Column Group II GP LP

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Tim Kutzkey's' Mailing Address?

  • Mailing address is 1700 Owens Street Suite 500 San Francisco CA 94158 CA

Ngm Biopharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
David J. Woodhouse, Ph.D. 2020 $525,000 $200,000 $3,833,880 $750 $4,559,630
David J. Woodhouse, Ph.D. 2019 $490,000 $125,000 $1,476,400 $750 $2,092,150
Siobhan Nolan Mangini 2020 $199,695 $155,000 $3,458,520 $750 $3,813,965
Jin-Long Chen, Ph.D. 2020 $515,000 $175,000 $1,677,323 $750 $2,368,073
Jin-Long Chen, Ph.D. 2019 $500,000 $125,000 $1,291,850 $750 $1,917,600
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1426332/000162828021007942/ngmbiopharmaceuticalsinc-d.htm

What are Ngm Biopharmaceuticals Inc's Past Insider Trades?

Ngm Biopharmaceuticals Inc's most recent insider trade came on June 13, 2022 by Group Column, Column Group GP Lp, Column Group Iii Lp, Column Group Iiia Lp, Column Group Iv Lp, Column Group Iva Lp, Column Group Iv GP Lp and Tcg Iv GP Llc who bought 984,161 units worth $13.29M . In the last 3 years, insiders at Ngm Biopharmaceuticals Inc have sold an estimated value of $12.36M and bought an estimated value of $346.83M worth of shares. Insider trading is most common in May, with the busiest year in 2019. The most active traders at the company are Group Column, Director,  David Goeddel V, Director,  and Peter Svennilson .

NGM BIOPHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1